Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB2916 Injection in Patients With Advanced Malignant Tumors
Clinical trial NCT05213767 · UNKNOWN
Trial details
- NCT number
- NCT05213767
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-01
- Primary completion
- 2023-05-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.